Medical Oncology

Melanoma inhibition by cyclooxygenase inhibitors: Role of interleukin-6 suppression, a putative mechanism of action, and clinical implications
pp. 1-6(6)
Author: Kast, R.

Hairy cell leukemia
pp. 7-15(9)
Authors: Swords, Ronan; Giles, Francis

Recent advances in the diagnosis and therapy of richter's syndrome
pp. 17-32(16)
Authors: Swords, Ronan; Bruzzi, John; Giles, Francis

Epirubicin, cisplatin, oral UFT, and leucovorin combination chemotherapy in advanced and metastatic esophageal cancer
pp. 33-37(5)
Authors: Choi, In; Seo, Hee; Sung, Hwa; Park, Kyong; Kim, Seok; Oh, Sang; Seo, Jae; Choi, Chul; Kim, Byung; Shin, Sang; Kim, Yeul; Kim, Jun

The efficacy of tamoxifen in patients with advanced epithelial ovarian cancer
pp. 39-43(5)
Authors: Karagol, Hakan; Saip, Pinar; Uygun, Kazim; Caloglu, Murat; Eralp, Yesim; Tas, Faruk; Aydiner, Adnan; Topuz, Erkan

The expression of Ki-67 and Bcl-2 in hodgkin's lymphoma: Correlation with the international prognostic score and bulky disease: A study by the serbian lymphoma study group (SLG)
pp. 45-53(9)
Authors: Jakovic, Ljubomir; Mihaljevic, Biljana; Jovanovic, Maja; Bogdanovic, Andrija; Martinovic, Vesna; Kravic, Tamara; Bumbasirevic, Vladimir

The influence of parental age and gender on anticipation in familial B-Cell malignancies
pp. 55-62(8)
Authors: Alexandrescu, Doru; Wiernik, Peter

Progression of bone marrow fibrosis in patients with essential thrombocythemia and polycythemia vera during anagrelide treatment
pp. 63-70(8)
Authors: Hultdin, Magnus; Sundström, Gunnel; Wahlin, Anders; Lundström, Berith; Samuelsson, Jan; Birgegård, Gunnar; Engström-Laurent, Anna

A clinical study of docetaxel with or without 5′DFUR as a second-line chemotherapy for advanced gastric cancer
pp. 71-75(5)
Authors: Maruta, Fukuto; Ishizone, Satoshi; Hiraguri, Manabu; Fujimori, Yoshiro; Shimizu, Fumiaki; Kumeda, Shigeyoshi; Miyagawa, Shinichi

Prognostic factors in gallbladder and biliary tract cancer
pp. 77-83(7)
Authors: Gómez-Roel, Xóchitl; Arrieta, Oscar; León-Rodríguez, Eucario

Dose dense (CEOP-14) vs dose dense and rituximab (CEOP-14+R) in high-risk diffuse large cell lymphoma
pp. 85-89(5)
Authors: Avilés, Agustin; Nambo, María; Neri, Natividad; Cleto, Sergio; Castañeda, Claudia; Huerta-Guzmàn, Judith; Murillo, Edgar; Contreras, Margarita; Talavera, Alejandra; González, Martha

Incidence of hypothyroidism after radiotherapy for nasopharyngeal carcinoma
pp. 91-94(4)
Authors: Ülger, Şükran; Ülger, Zekeriya; Yildiz, Ferah; Özyar, Enis

Anemia and quality of life including anemia-related symptoms in patients with solid tumors in clinical practice
pp. 95-102(8)
Authors: Bremberg, E.; Brandberg, Y.; Hising, C.; Friesland, S.; Eksborg, S.

Prolonged survival of a patient with lung cancer after treatment with S-1, a new oral fluoropyrimidine anticancer drug
pp. 103-107(5)
Authors: Urata, Yoshiko; Negoro, Shunichi; Satouchi, Miyako; Kurata, Takayasu; Yoshimura, Sho; Shimada, Temiko; Takada, Yoshiki

Adult T-cell leukemia/lymphoma presenting with bilateral hearing loss: A case report
pp. 109-113(5)
Authors: Lee, Sung; Wiernik, Peter

Paraneoplastic pemphigus associated with fludarabine use
pp. 115-118(4)
Authors: Yildiz, Ozcan; Ozguroglu, Mustafa; Yanmaz, M.; Turna, Hande; Kursunoglu, Sabiha; Antonov, Meltem; Serdaroglu, Server; Demirkesen, Cuyan; Buyukunal, Evin

Thymoma with chronic diarrhea: Report of two cases and review of the literature
pp. 119-123(5)
Authors: Yildiz, Ozcan; Ozguroglu, Mustafa; Turna, Hande; Yanmaz, Teoman; Kaynak, Kamil; Akman, Canan; Cetin, Sibel; Oz, Buge; Celik, Aykut